Business Description
MapLight Therapeutics is a clinical-stage company based in Redwood City, California, focused on developing treatments for serious brain and nervous system conditions such as schizophrenia, Parkinson's disease, autism spectrum disorder, and Alzheimer's disease. The company has built a pipeline of several drug candidates, each targeting specific neurological pathways linked to these conditions. Founded in 2018 and formerly known as Alvarado Therapeutics, MapLight combines drug development with its own research platform designed to identify the brain circuits that drive disease.
